Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board
December 4, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
PsyBio Therapeutics and Leo Acquisitions Announce Closing of CAD$14.5 Million Oversubscribed Private Placement
December 4, 2020
Ryan Allway December 4th, 2020 Psychedelics PsyBio Therapeutics, Inc. (“PsyBio”) and Leo Acquisitions Corp. (NEX: LEQ.H) (“Leo”) are pleased to announce the closing of the previously announced brokered private placement (the “Financing”) of subscription receipts (the “Subscription Receipts”) of PsyBio Therapeutics Financing Inc. (“Finco”), a special purpose British Columbia... Read more
Havn Life Sciences Partners With Veterans Mental Health Non-Profit, Westwood Institute
December 4, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Field Trip Health Ltd. Provides Operational and Investor Update
December 4, 2020
Ryan Allway December 4th, 2020 Psychedelics Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) (“Field Trip”), a leader in the development and delivery of psychedelic therapies, is pleased to announce that, in response to significant interest from people and medical professionals in Canada, it is expanding the hours of... Read more
Lobe Sciences Commences Engineering of Nasal Mist Device
December 4, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021
Marijuana Stocks, Finance, & InvestingUncategorized December 4, 2020
Entheon announces an agreement for the purpose of conducting a Phase 1 clinical trial.
Read more
BIG Psychedelics Financings Powering Future Investor Profits
Marijuana Stocks, Finance, & InvestingUncategorized December 4, 2020
Nearly half a billion dollars has recently flooded into the coffers of psychedelic drug companies. That’s enough capital to power a lot of growth.
Read more
